QUANTA INC
company.status.inactiveCIK 1691430fmd_18NY0PK7S7RX1DVCXEC1YJESTEManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: May 01, 2016 to Mar 31, 2022, 26 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|
| Total revenues | 0 | 0 | 1 | 1 |
| Cost of revenue | 0 | 0 | 0 | 0 |
| Gross profit | 0 | 0 | 1 | 1 |
| Research and development | 0 | 0 | 0 | 0 |
| Selling, general and administrative | – | – | 5 | 4 |
| Compensation and benefits | 0 | – | 1 | – |
| Total operating expenses | – | – | 6 | 6 |
| Operating income | 0 | 0 | (5) | (5) |
| Interest expense | – | – | – | 0 |
| Other non-operating income (expense) | – | – | (0) | (3) |
| Income before taxes | (0) | (0) | – | – |
| Income tax expense | 0 | 0 | – | – |
| Net income from continuing operations | (0) | (0) | – | – |
| Net income | (0) | (0) | (6) | (8) |